Antiepileptic treatment is associated with bone loss: Difference in drug type and region of interest

Journal of Nuclear Medicine Technology

Volumn 41, Issue 3, 2013, Pages 208-211

  Salimipour, Hooman ^a   Kazerooni, Sara ^a   Seyedabadi, Mohammad ^a   Nabipour, Iraj ^a   Nemati, Reza ^a   Iranpour, Darioush ^a   Assadi, Majid ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antiepileptic drugs (AEDs); Bone mineral density (BMD); Convulsion; Dual energy x ray absorptiometry (DXA)

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ENZYME INDUCING AGENT; ETHOSUXIMIDE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BONE DENSITY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EPILEPSY; FEMALE; FEMUR NECK; FOREARM; GREATER TROCHANTER; HIP; HUMAN; LESSER TROCHANTER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREDICTIVE VALUE; QUESTIONNAIRE; SCHOOL CHILD; SIDE EFFECT; SPINE;

ANTIEPILEPTIC DRUGS (AEDS); BONE MINERAL DENSITY (BMD); CONVULSION; DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA);

ANTICONVULSANTS; BONE DENSITY; BONE DISEASES; FEMALE; HUMANS; MALE; YOUNG ADULT;

EID: 84884941804     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.113.124685     Document Type: Article

References (22)

1. Mazziotti G, Canalis E, Giustina A. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med. 2010;123:877-884.
2. Lee RH, Lyles KW, Colon-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother. 2010;8:34-46.
3. Dent CE, Richens A, Rowe DJ, Stamp TC. Osteomalacia with long-term anticonvulsant therapy in epilepsy. BMJ. 1970;4:69-72.
4. Hahn TJ, Hendin BA, Scharp CR, Haddad JG Jr. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med. 1972; 287:900-904.
5. Hahn TJ, Birge SJ, Scharp CR, Avioli LV. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest. 1972;51:741-748.
6. Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006;47: 510-515.
7. Cerveny L, Svecova L, Anzenbacherova E, et al. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos. 2007;35:1032-1041.
8. Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008;70:1586-1593.
9. Filardi S, Guerreiro CA, Magna LA, Marques Neto JF. Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr. 2000;58:616-620.
10. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001;57:445-449.
11. Elliott JO, Jacobson MP, Haneef Z. Homocysteine and bone loss in epilepsy. Seizure. 2007;16:22-34.
12. Boluk A, Guzelipek M, Savli H, Temel I, Ozisik HI, Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res. 2004;50:93-97.
13. Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure. 1999;8:339-342.
14. Selby PL, McCloskey EV, Robinson J, et al. Is a calculated total hip BMD of clinical use? Osteoporosis International. 2000;11:368-371.
15. Lu Y, Fuerst T, Hui S, Genant HK. Standardization of bone mineral density at femoral neck, trochanter andWard's triangle. Osteoporosis International. 2001;12: 438-444.
16. Chou IJ, Lin KL, Wang HS, Wang CJ. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan. 2007;48:317-322.
17. Lee RH, Lyles KW, Sloane R, Colon-Emeric C. The association of newer anticonvulsant medications and bone mineral density. Endocr Pract. September 14, 2012 [Epub ahead of print].
18. Carbone LD, Johnson KC, Robbins J, et al. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res. 2010;25:873-881.
19. Andress DL, Ozuna J, Tirschwell D, et al. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol. 2002;59:781-786.
20. Lyngstad-Brechan MA, Tauboll E, Nakken KO, et al. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy. Scand J Clin Lab Invest. 2008;68:759-766.
21. Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology. 2004;62:2051-2057.
22. Elliott JO. Possible methods for the prevention of bone loss in persons with epilepsy. Expert Rev Neurother. 2009;9:797-812.